Weide Zhong
Impact in
- Cancer Research top 1%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
- Molecular Biology top 2%
- RNA modifications and cancer
- Circular RNAs in diseases
- Signaling Pathways in Disease
Papers in
-
- Cancer, Lipids, and Metabolism 23
- Cancer, Hypoxia, and Metabolism 22
- Cancer-related molecular mechanisms research 17
- MicroRNA in disease regulation 15
-
- Prostate Cancer Treatment and Research 50
- Co-authors
- Zhaodong HanHuichan HeFuneng JiangQi-Shan DaiYuxiang LiangJianguo ZhuXue‐cheng BiChin‐Lee Wu
- Journals
- Medical Oncology (8 papers)Clinical and investigative medicine (6 papers)Frontiers in Oncology (5 papers)Cancer Letters (4 papers)Pathology & Oncology Research (4 papers)
- Partner nations
- ChinaUnited StatesMacao
In The Last Decade
Weide Zhong
207 papers receiving 4.6k citations
Peers
Comparison fields: 5 of 133
- Cancer Research 1.7k
- Molecular Biology 2.8k
- Pulmonary and Respiratory Medicine 1.1k
- Oncology 879
- Immunology 490
Countries citing papers authored by Weide Zhong
This map shows the geographic impact of Weide Zhong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weide Zhong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weide Zhong more than expected).
Fields of papers citing papers by Weide Zhong
This network shows the impact of papers produced by Weide Zhong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weide Zhong. The network helps show where Weide Zhong may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Weide Zhong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 7 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 9 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 11 | |
| 7 | 2023 | 12 | |
| 8 | 2022 | 26 | |
| 9 | 2022 | 13 | |
| 10 | 2021 | 83 | |
| 11 | 2020 | 51 | |
| 12 | 2020 | 13 | |
| 13 | 2020 | 11 | |
| 14 | Carbon Nanospheres Exert Antitumor Effects Associated with Downregulation of 4E-BP1 Expression on Prostate Cancer | 2020 | 1 |
| 15 | Aberrant Expression of Citrate Synthase is Linked to Disease Progression and Clinical Outcome in Prostate Cancer | 2020 | 3 |
| 16 | 2018 | 88 | |
| 17 | 2018 | 153 | |
| 18 | 2018 | 32 | |
| 19 | 2015 | 103 | |
| 20 | 2008 | 57 |
About Weide Zhong
Weide Zhong is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine, Molecular Biology, Oncology and Immunology and Allergy, having authored 217 papers that have together received 4.7k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (50 papers), Cancer, Lipids, and Metabolism (23 papers), Cancer, Hypoxia, and Metabolism (22 papers), Cancer-related gene regulation (18 papers), Epigenetics and DNA Methylation (18 papers), Cancer-related molecular mechanisms research (17 papers), MicroRNA in disease regulation (15 papers) and Signaling Pathways in Disease (14 papers). The work is most often cited by research in Cancer Research (1.7k citations), Molecular Biology (2.8k citations), Pulmonary and Respiratory Medicine (1.1k citations), Oncology (879 citations) and Immunology (490 citations). Weide Zhong has collaborated with scholars based in China, United States and Macao. Frequent co-authors include Zhaodong Han, Huichan He, Funeng Jiang, Qi-Shan Dai, Yuxiang Liang, Jianguo Zhu, Xue‐cheng Bi, Chin‐Lee Wu, Chao Cai and Yangjia Zhuo. Their work appears in journals such as Medical Oncology, Clinical and investigative medicine, Frontiers in Oncology, Cancer Letters and Pathology & Oncology Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.